Drug profile · INN
theophylline sodium glycinate
ASBRON
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
theophylline sodium glycinate (ASBRON) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN theophylline sodium glycinate
Brand ASBRON
Route ORAL
Formulation ELIXIR
Frequently asked questions
What is theophylline sodium glycinate?
theophylline sodium glycinate (ASBRON) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for theophylline sodium glycinate?
ASBRON is a marketed brand name for theophylline sodium glycinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of theophylline sodium glycinate?
theophylline sodium glycinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.